Please login to the form below

Not currently logged in
Email:
Password:

Decibel Therapeutics expands leadership team

John Keilty, Dr Troyen Brennan, Roger Brown and Dr George Scangos join

Decibel Therapeutics John KeiltyHearing disorders specialist Decibel Therapeutics has expanded its leadership team and board of directors with four new appointments.

John Keilty (pictured right) becomes chief data sciences officer, moving to the Cambridge, Massachusetts-based firm from Third Rock Ventures where he was general manager of platform operations.

Prior to this, Keilty served as vice president of information technology and informatics at Infinity Pharmaceuticals, and held a number of positions at Millennium Pharmaceuticals working with the company's core genomic technologies.

Decibel Therapeutics Dr Troyen BrennanMeanwhile, Dr Troyen Brennan, Roger Brown and Dr George Scangos have been appointed to Decibel's board of directors.

Dr Brennan (pictured left) currently serves as executive vice president and chief medical officer of CVS Health, with responsibility for the firm's medical affairs and healthcare strategy.

Previously, he was chief medical officer of Aetna Inc, and served as president and chief executive officer of Brigham and Women's Physicians Organization.

Decibel Therapeutics Roger BrownBrown (pictured below right) has been president of Berklee College of Music since 2004, and created and leads its global online music education system.

He co-founded Bright Horizons Family Solutions, a worksite childcare and early education provider, and prior to this served as co-director of Save the Children's Sudan operations. 

Finally, Dr Scangos (pictured below left) has recently become chief executive officer of viral and bacterial diseases specialist Vir Biotechnology, having previously served as chief executive officer of Biogen from 2010 until 2016. 

Prior to this, he was president and chief executive of Exelixis and served as president of Bayer Biotechnology, overseeing the business development, manufacturing and R&D of the company's biological products. 

Decibel Therapeutics Dr George ScangosSteve Holtzman, president and chief executive of Decibel Therapeutics, said: “We are thrilled to welcome John, Troy, Roger and George to Decibel's distinguished team as we seek to create a world in which the benefits and joys of hearing are available to all.

“Achieving Decibel's mission will require the integration of a broad range of diverse perspectives and multidisciplinary excellence. Our new board members are all leaders in their respective fields and exceptionally broad thinkers, and I'm thrilled that John has decided to join our leadership team, after working with us part-time during his tenure at Third Rock.”

23rd January 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics